| Company Name: | Advisory Board Company | | Ticker Symbol: | ABCO | | | WWW Address: | www.advisoryboardcompany.com |
| CEO: | Mr. Robert W. Musslewhite | | No. of Employees: | 1,850 |
| Common Issue Type: | CS | | Business Description: | Advisory Board Company provides best practices research and analysis, business intelligence and software tools, and installation support and management and advisory services to organizations including hospitals, health systems etc.
|
| | | Industry Information: | DIVERSIFIED SERVICES - Business Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 54.53 |  0.58 | 51.57 | 57.59 | 54.12 | 53.53 | 52.14 | 102709 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 1,935.8 | 35.5 | 0.56 | 0.61 | 0.00 | 87.5 | 0.0 | 55.06 - 39.73 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 53.37 | $ | | PE Ratio - LTM | 87.5 | |
| Market Capitalisation | 1,935.8 | mil |
| Latest Shares Outstanding | 35.5 | mil |
| Earnings pS (EPS) | 0.61 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 187,849 | $ |
| Effective Tax Rate | 43.9 | % |
| Float | 34.3 | mil |
| Float as % of Shares Outstanding | 99.4 | % |
| Foreign Sales | 16 | mil |
| Domestic Sales | 435 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 32.70 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 47.2 | % |
| EBITDA Margin | 14.5 | % |
| Pre-Tax Profit Margin | 8.7 | % |
| Assets Turnover | 0.6 | % |
| Return on Assets (ROA) | 2.5 | % |
| Return on Equity (ROE) | 7.8 | % |
| Return on Capital Invested (ROCI) | 7.8 | % |
| Current Ratio | 0.9 | |
| Leverage Ratio (Assets/Equity) | 3.1 | |
| Interest Cover | 0.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.00 | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | -0.95 | $ |
| Cash pS | 1.63 | $ |
| Book-Value pS | 7.93 | $ |
| Tangible Book-Value pS | 4.32 | $ |
| Cash Flow pS | 1.24 | $ |
| Free Cash Flow pS | 0.31 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 6.73 | |
| Price/Tangible Book Ratio | 12.34 | |
| Price/Cash Flow | 43.1 | |
| Price/Free Cash Flow | 170.7 | |
| P/E as % of Industry Group | 244.0 | % |
| P/E as % of Sector Segment | 267.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.6 | 102 | 2,054 | 5,277 |
| 4 Weeks | 53.82 | 49.61 | 49.96 | 6.8 | 109 | 2,206 | 39,704 |
| 13 Weeks | 53.82 | 44.20 | 49.71 | 7.4 | 102 | 2,836 | 175,812 |
| 26 Weeks | 55.06 | 44.20 | 48.61 | 9.8 | 95 | 2,589 | 318,496 |
| 52 Weeks | 55.06 | 39.73 | 48.01 | 11.2 | 91 | 2,363 | 585,954 |
| YTD | 55.06 | 44.20 | - | 14.1 | 99 | 2,641 | 298,423 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 52.97 | 52.60 | 50.02 | 50.03 | 49.06 | 0.56 | -0.25 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 16.11 | 92.3 | 23.91 |
| Income | -2.63 | 2.9 | 19.68 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 42.58 | NA | 54.28 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | -4.20 | NA | 3.16 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 21.7 | 25.0 | 21.7 |
| Earnings % | -12.8 | -21.6 | -12.8 |
| EPS % | -16.4 | -26.1 | -16.4 |
| EPS $ | -0.12 | -0.06 | -0.12 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | -3.84 |
| Current Ratio | 0.9 |
| Quick Ratio (Acid Test) | 0.9 |
| Liquidity Ratio (Cash) | 0.15 |
| Receivables Turnover | 1.4 |
| Average Collection Period | 257 |
| Working Capital/Equity | -12.0 |
| Working Capital pS | -0.96 |
| Cash-Flow pS | 1.25 |
| Free Cash-Flow pS | 0.32 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 2.54 |
| Financial Leverage Ratio (Assets/Equity) | 3.1 |
| Debt Ratio | 67.9 |
| Total Debt/Equity (Gearing Ratio) | 0.00 |
| LT Debt/Equity | 0.00 |
| LT Debt/Capital Invested | 40.3 |
| LT Debt/Total Liabilities | 0.0 |
| Interest Cover | 0.0 |
| Interest/Capital Invested | 0.00 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 24.91 |
| Tobin's Q Ratio | 2.16 |
| Current P/E Ratio - LTM | 87.50 |
| Enterprise Value (EV)/EBITDA | 36.96 |
| Enterprise Value (EV)/Free Cash Flow | 204.56 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 12.34 |
| Price/Book Ratio - LTM | 6.73 |
| Price/Cash Flow Ratio | 43.1 |
| Price/Free Cash Flow Ratio - LTM | 170.7 |
| Price/Sales Ratio | 4.20 |
| P/E Ratio (1 month ago) - LTM | 81.4 |
| P/E Ratio (26 weeks ago) - LTM | 62.3 |
| P/E Ratio (52 weeks ago) - LTM | 65.8 |
| 5-Y High P/E Ratio | 90.3 |
| 5-Y Low P/E Ratio | 10.3 |
| 5-Y Average P/E Ratio | 49.9 |
| Current P/E Ratio as % of 5-Y Average P/E | 175 |
| P/E as % of Industry Group | 244.0 |
| P/E as % of Sector Segment | 267.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 87.5 |
| PER SHARE FIGURES |
| LT Debt pS | 0.00 |
| Current Liabilities pS | 13.74 |
| Tangible Book Value pS - LTM | 4.32 |
| Book Value pS - LTM | 7.93 |
| Capital Invested pS | 7.93 |
| Cash pS - LTM | 1.63 |
| Cash Flow pS - LTM | 1.24 |
| Free Cash Flow pS - LTM | 0.31 |
| Earnings pS (EPS) | 0.61 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 2.46 |
| Free Cash Flow Margin 5YEAR AVG | 5.59 |
| Net Profit Margin | 4.9 |
| Net Profit Margin - 5YEAR AVRG. | 6.2 |
| Equity Productivity | 1.60 |
| Return on Equity (ROE) | 7.8 |
| Return on Equity (ROE) - 5YEAR AVRG. | 11.5 |
| Capital Invested Productivity | 1.60 |
| Return on Capital Invested (ROCI) | 7.8 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 11.5 |
| Assets Productivity | 0.60 |
| Return on Assets (ROA) | 2.5 |
| Return on Assets (ROA) - 5YEAR AVRG. | 3.6 |
| Gross Profit Margin | 47.2 |
| Gross Profit Margin - 5YEAR AVRG. | 48.1 |
| EBITDA Margin - LTM | 14.5 |
| EBIT Margin - LTM | 8.7 |
| Pre-Tax Profit Margin | 8.7 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 9.8 |
| Effective Tax Rate | 43.9 |
| Effective Tax Rate - 5YEAR AVRG. | 37.0 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 281 |
| Revenue per Employee | 187,849 |
| Net Income per Employee | 9,190 |
| Average Collection Period | 281 |
| Receivables Turnover | 1.4 |
| Day's Inventory Turnover Ratio | |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 16.66 |
| Assets/Revenue | 1.67 |
| Net Working Capital Turnover | -13.39 |
| Fixed Assets Turnover | 1.05 |
| Total Assets Turnover | 0.6 |
| Revenue per $ Cash | 7.80 |
| Revenue per $ Plant | 6.33 |
| Revenue per $ Common Equity | 1.60 |
| Revenue per $ Capital Invested | 1.60 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 32.7 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 34.0 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |
